Tirzepatide
FAQs
Tirzepatide is a once-weekly injection that combines GLP-1 and GIP receptor agonists to deliver powerful effects on appetite control and metabolic health. By targeting two key hormonal pathways, tirzepatide offers enhanced benefits for weight management, including reduced food intake and improved blood sugar control.
While every person is unique, the target weight loss for tirzepatide patients is 1-3 pounds per week.
Similar to semaglutide, Tirzepatide effectively lowers blood sugar levels and HbA1c in individuals with type 2 diabetes or prediabetes. This medication enhances cardiovascular health by lowering cholesterol levels and reducing the risk of heart disease. It also been shown to improve kidney and liver health.
Similar to semaglutide, tirzepatide patients can experience GI-related side effects, though the side effects of tirzepatide are milder than semaglutide. The most common side are nausea and fatigue. Our healthcare providers work with patients step-by-step to ensure that they are losing weight in a sustainable way with limited side effects.